{"doi":"10.1111/j.1523-1755.2004.00520.x","title":"Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients","abstract":null,"journal":"Kidney International","year":2004,"id":25511,"datarank":10.554715006613245,"base_score":5.529429087511423,"endowment":5.529429087511423,"self_citation_contribution":0.8294143631267137,"citation_network_contribution":9.72530064348653,"self_endowment_contribution":0.8294143631267137,"citer_contribution":9.72530064348653,"corpus_percentile":null,"corpus_rank":null,"citation_count":251,"citer_count":200,"citers_with_citation_signal":170,"citers_with_endowment":170,"datacite_reuse_total":16,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":149916,"name":"Joel A. Dubin","orcid":null,"position":1,"is_corresponding":false},{"id":149917,"name":"Hans-Georg Müller","orcid":null,"position":2,"is_corresponding":false},{"id":149918,"name":"Laura Rosales","orcid":null,"position":3,"is_corresponding":false},{"id":149919,"name":"Nathan W. Levin","orcid":null,"position":4,"is_corresponding":false},{"id":29446,"name":"William E. Mitch","orcid":null,"position":5,"is_corresponding":false},{"id":149920,"name":"the HEMO Study Group","orcid":null,"position":6,"is_corresponding":false},{"id":149915,"name":"George A. Kaysen","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.529429087511423,"endowment":5.529429087511423,"datacite_reuse_total":16,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15086482","pmcid":null,"openalex_id":"https://openalex.org/W2036285678","authors":[],"funders":[{"funder_name":"NCRR NIH HHS","grant_id":"M01 RR 00039","title":null},{"funder_name":"NIDDK NIH HHS","grant_id":"R01 DK 50777","title":null}],"total_grants":2,"fwci":5.1038,"citation_percentile":0.95982987,"influential_citations":0,"citation_trend":[{"year":2012,"count":11},{"year":2013,"count":7},{"year":2014,"count":13},{"year":2015,"count":9},{"year":2016,"count":7},{"year":2017,"count":13},{"year":2018,"count":18},{"year":2019,"count":12},{"year":2020,"count":17},{"year":2021,"count":13},{"year":2022,"count":14},{"year":2023,"count":15},{"year":2024,"count":18},{"year":2025,"count":13},{"year":2026,"count":5}],"oa_status":"closed","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.kidney-international.org/article/S0085253815498515/pdf","host_type":"BRONZE"},{"url":"https://api.elsevier.com/content/article/PII:S0085253815498515?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0085253815498515?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1111/j.1523-1755.2004.00520.x","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15086482","host_type":"repository"}],"fields_of_study":["Dialysis and Renal Disease Management","Protein Interaction Studies and Fluorescence Analysis","Chronic Kidney Disease and Diabetes","Chemistry","Medicine","Acute-Phase Reaction","Adult","Aged","Aged, 80 and over","C-Reactive Protein","Ceruloplasmin","Female","Humans","Interleukin-6","Male","Middle Aged","Orosomucoid","Osmolar Concentration","Renal Dialysis","Serum Albumin"],"mesh_terms":["Acute-Phase Reaction","Adult","Aged","Aged, 80 and over","C-Reactive Protein","Ceruloplasmin","Female","Renal Dialysis","Humans","Male","Middle Aged","Orosomucoid","Osmolar Concentration","Serum Albumin","Interleukin-6"],"keywords":["Albumin","Serum albumin","Internal medicine","Acute-phase protein","Hemodialysis","Endocrinology","Catabolism","Transferrin","Inflammation","Ceruloplasmin","Chemistry","Medicine","Immunology","Metabolism"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.12028194.v1","title":"Additional file 1 of Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028194","title":"Additional file 1 of Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24580407.v1","title":"Additional file 1 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24580407","title":"Additional file 1 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24580490.v1","title":"Additional file 2 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24580490","title":"Additional file 2 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640925.v1","title":"Additional file 3 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640925","title":"Additional file 3 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640928.v1","title":"Additional file 4 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640931.v1","title":"Additional file 5 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640928","title":"Additional file 4 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640931","title":"Additional file 5 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640934.v1","title":"Additional file 6 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26640934","title":"Additional file 6 of Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028203.v1","title":"Additional file 2 of Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.12028203","title":"Additional file 2 of Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients","publisher":"figshare","resource_type":"Dataset"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T05:08:17.466362Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}